LNW Overview

Analyst Upgrades and Downgrades: JP Morgan downgraded Argan Inc while raising its price target, Oppenheimer maintained an Outperform rating for Amazon with a price target increase, and RBC Capital downgraded PTC Therapeutics despite raising its price target.

Price Target Adjustments: Barclays lowered Crown Castle's price target and downgraded its rating, while Benchmark raised Light & Wonder's target and maintained a Buy rating.

Significant Increases: Mizuho raised Insmed's price target significantly and maintained an Outperform rating, while HSBC upgraded Thermo Fisher Scientific from Hold to Buy with a notable price target increase.

Mixed Ratings: Argus Research cut Target's price target but kept a Buy rating, and BMO Capital reduced Old Dominion's target while upgrading its rating to Outperform.

Market Performance: Sporting goods and activities shares are down approximately 1.5%, with notable declines from Aureus Greenway Holdings (down 4.4%) and Light & Wonder (down 3.7%).

Sector Laggards: The paper and forest products sector, along with sporting goods, are identified as laggards in the market on Friday.

Video Content: A video segment highlights the Friday sector laggards, focusing on the performance of paper, forest products, and sporting goods.

Author's Perspective: The views expressed in the article are those of the author and do not necessarily represent the opinions of Nasdaq, Inc.

Court Ruling Update: The Nevada Court has granted Aristocrat's motion to obtain discovery of math models for certain Light & Wonder games released since 2021, despite Light & Wonder's disappointment with the ruling.

Ongoing Litigation Timeline: The US litigation process continues, with fact discovery set to close on December 15, 2025, and expert discovery closing on March 16, 2026.